Loading viewer...
investor_presentation
Format: PDF investor_presentation
This investor presentation by RNXT outlines their late-stage clinical biopharmaceutical advancements and future strategies for treating solid tumors.
investor_presentation
49 Pages
Rice Midstream Partners
investor_presentation
4D Pharma